Select the date you received service so we can correctly redirect you:
On or before November 1, 2017
On November 2, 2017 or after
If you would like to speak with a customer service representative, you can reach them at (888) 274-7849 between the hours of 8:00am-5:00pm cst.
The latest COVID-19 information from VUMC.
VU to lead $2 million prostate cancer treatment research effort (5/23/2013)
Recently Reported Long-term Outcomes Could Motivate More Men with Prostate Cancer to Consider Active Surveillance (4-15-2013)
Similar 15-year Functional Outcomes after Prostatectomy or Radiotherapy for Localized Prostate Cancer (4-15-2013)
Urologic Surgery and Engineering team to develop telerobots for use in bladder surgery (4-3-2013)
Barocas discusses importance of doctor/patient communications before considering treatment, Scientific American magazine (3-5-2013)
Long-term effects of prostate therapies tracked (1-31-2013)
Grogan discusses minimally invasive lung cancer surgery in CURE magazine (12-2012)
Massion named to lead Cancer Center's Thoracic Program (11-29-2012)
Wellons named chief of Pediatric Neurosurgery (9-20-2012)
Vanderbilt-led study reveals racial disparities in prostate cancer care (8-30-2012)
Mixed results define 2012 Tennessee Men's Health Report Card (6-14-2012)
Penson appointed to AHRQ National Advisory Council (3-22-2012)
New fellowship focuses on female pelvic medicine (8-4-2011)
Dunn elected into surgery association (12-16-2010)
VICC wins grant to study prostate cancer treatments (10-7-2010)
Urologic Surgery thrives on team approach (8-4-2011)
Study seeks to improve early diagnosis, treatment of lung cancer (4-22-2010)
David Penson, MD, MPH, will serve as a member of the Health Services Organization and Delivery (HSOD) Study Section of the NIH's Center for Scientific Review through June 30, 2015.